The Leader in Detecting Ocular Biomarkers for Diseases of the Eye, Heart, and Brain
Amydis Powers AI to Enable Precision Healthcare
Amydis is the leader in developing a new class of ocular tracers that enable digital detection and monitoring of human disease-related molecular biomarkers through standard ocular imaging cameras. This pioneering technology can accelerate diagnosis, improve the clinical testing of novel therapeutics and revolutionize treatment.
The Journey to a Diagnosis is often a Race Against Time
